NCT07236398

Brief Summary

Atrial fibrillation (AF) is the most common sustained arrhythmia and affects up to 60% of patients undergoing cardiac surgery. Restoring sinus rhythm improves symptoms, reduces stroke risk, and prevents heart failure. Despite guideline recommendations, surgical ablation remains underused. This study evaluates the safety and effectiveness of a standardized modified left atrial Maze procedure performed concomitantly with cardiac surgery and identifies early predictors of long-term rhythm success. The procedure consists of creating left atrial lesion sets using radiofrequency, cryothermy, or both, and systematically closing the left atrial appendage to reduce thromboembolic risk. This prospective single-center observational study includes 151 patients undergoing concomitant AF ablation. Follow-up is performed at 3, 6, and 12 months with clinical evaluation, ECG, 24-hour Holter monitoring, pacemaker interrogation when applicable, and a standardized quality-of-life questionnaire. The primary endpoint is sinus rhythm maintenance at 12 months. Secondary endpoints include operative mortality, neurological events, pacemaker implantation, reoperation for bleeding, and quality-of-life changes. The study aims to provide new insights into predictors of success and support standardized follow-up strategies for surgical AF ablation.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
151

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2023

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

November 15, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 19, 2025

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

December 5, 2025

Status Verified

November 1, 2025

Enrollment Period

2.4 years

First QC Date

November 15, 2025

Last Update Submit

November 30, 2025

Conditions

Keywords

atrial fibrillationsurgical ablationleft Mazecardiac surgeryrythm monitoring

Outcome Measures

Primary Outcomes (1)

  • Maintenance of sinus rhythm at 12 months after modified left atrial Maze procedure, assessed by 24-hour Holter monitoring or pacemaker interrogation

    Sinus rhythm will be assessed at 12 months post-ablation using 24-hour Holter monitoring or pacemaker interrogation. Early rhythm assessment at 3 months is also performed for monitoring purposes.

Interventions

Patients undergo a standardized modified left atrial Maze procedure during cardiac surgery. The procedure includes pulmonary vein isolation using a BOX lesion set (bipolar radiofrequency clamp) for non-mitral surgeries, and an additional mitral line performed with cryotherapy for mitral valve surgeries. Left atrial appendage closure is systematically performed by excision-suture or AtriClip placement. Postoperative management includes beta-blockers, amiodarone when indicated, and lifelong anticoagulation according to guidelines. Rhythm evaluation is conducted at 3 and 12 months using ECG, 24-hour Holter monitoring, or pacemaker interrogation, along with quality-of-life assessment.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This prospective single-center observational cohort includes adult patients with documented atrial fibrillation undergoing cardiac surgery at the University Hospital of Toulouse. All eligible patients during the inclusion period were consecutively enrolled and followed for one year.

You may qualify if:

  • Age 18 years or older
  • Documented history of atrial fibrillation
  • Scheduled for cardiac surgery
  • Able to understand study information and provide non-opposition consent

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Myriam ADDI

Toulouse, French (France), 31400, France

Location

MeSH Terms

Conditions

Atrial FibrillationArrhythmias, Cardiac

Interventions

Cardiac Surgical Procedures

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cardiovascular Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical Procedures

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Department of Cardiovascular Surgery, University Hospital of Toulouse

Study Record Dates

First Submitted

November 15, 2025

First Posted

November 19, 2025

Study Start

June 8, 2023

Primary Completion

November 15, 2025

Study Completion

December 15, 2025

Last Updated

December 5, 2025

Record last verified: 2025-11

Locations